- Home
- WERN vs BBNX Comparison
WERN vs BBNX Comparison
Compare WERN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WERN | BBNX |
|---|---|---|
| Founded | 1956 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | WERN | BBNX |
|---|---|---|
| Price | $30.66 | $29.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 11 |
| Target Price | $26.23 | ★ $28.09 |
| AVG Volume (30 Days) | ★ 956.6K | 672.2K |
| Earning Date | 10-30-2025 | 10-28-2025 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $2,991,440,000.00 | $88,570,000.00 |
| Revenue This Year | $1.18 | $52.13 |
| Revenue Next Year | $4.50 | $36.16 |
| P/E Ratio | $74.48 | ★ N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $23.02 | $8.89 |
| 52 Week High | $40.12 | $32.71 |
Technical Indicators
Market Signals| Indicator | WERN | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 73.12 | 56.71 |
| Support Level | $25.20 | $28.00 |
| Resistance Level | $31.25 | $30.50 |
| Average True Range (ATR) | 1.01 | 1.82 |
| MACD | 0.51 | -0.26 |
| Stochastic Oscillator | 91.13 | 38.33 |
Price Performance
Historical ComparisonAbout WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.